• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bcl-2的异位表达而非Bcl-xL的异位表达可使Ramos B细胞免于Fas介导的凋亡。

Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis.

作者信息

Alam M K, Davison S, Siddiqui N, Norton J D, Murphy J J

机构信息

Infection and Immunity Research Group, Division of Life Sciences, King's College London, GB.

出版信息

Eur J Immunol. 1997 Dec;27(12):3485-91. doi: 10.1002/eji.1830271249.

DOI:10.1002/eji.1830271249
PMID:9464838
Abstract

The human Burkitt lymphoma Ramos B cell line can be induced to undergo apoptosis in response to a variety of different agents, including calcium ionophores, anti-immunoglobulin (Ig) and macromolecular synthesis inhibitors. In addition, following up-regulation of the Fas (CD95) surface receptor by CD40 ligation, these cells also become susceptible to apoptosis induction by Fas ligation. We have previously shown that protection from calcium ionophore- and macromolecular synthesis inhibitor-induced apoptosis by CD40 ligation is associated with a rapid up-regulation of Bcl-xL followed by a more moderate and delayed up-regulation of Bcl-2. We show here that overexpression of Bcl-xL, like Bcl-2, protects Ramos cells from apoptosis induction in response to calcium ionophore, anti-Ig and macromolecular synthesis inhibition. However, in contrast to Bcl-2, ectopic overexpression of Bcl-xL does not rescue from Fas-mediated apoptosis. Thus, in Ramos B cells, the Fas apoptotic pathway exhibits differential sensitivity to inhibition by Bcl-2 family members. These findings also suggest that CD40 signaling provides a switch which renders the cells susceptible to Fas-ligand mediated apoptosis through up-regulation of Fas whilst affording protection from anti-Ig-induced apoptosis through up-regulation of Bcl-xL.

摘要

人伯基特淋巴瘤Ramos B细胞系可被多种不同因子诱导发生凋亡,这些因子包括钙离子载体、抗免疫球蛋白(Ig)和大分子合成抑制剂。此外,在通过CD40连接上调Fas(CD95)表面受体后,这些细胞也会变得易于被Fas连接诱导凋亡。我们之前已经表明,CD40连接对钙离子载体和大分子合成抑制剂诱导的凋亡的保护作用与Bcl-xL的快速上调相关,随后是Bcl-2更为适度和延迟的上调。我们在此表明,与Bcl-2一样,Bcl-xL的过表达可保护Ramos细胞免受钙离子载体、抗Ig和大分子合成抑制诱导的凋亡。然而,与Bcl-2不同,Bcl-xL的异位过表达不能挽救Fas介导的凋亡。因此,在Ramos B细胞中,Fas凋亡途径对Bcl-2家族成员的抑制表现出不同的敏感性。这些发现还表明,CD40信号传导提供了一个开关,通过上调Fas使细胞易于受到Fas配体介导的凋亡,同时通过上调Bcl-xL提供对抗Ig诱导的凋亡的保护。

相似文献

1
Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis.Bcl-2的异位表达而非Bcl-xL的异位表达可使Ramos B细胞免于Fas介导的凋亡。
Eur J Immunol. 1997 Dec;27(12):3485-91. doi: 10.1002/eji.1830271249.
2
Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.CD40的连接增强了Fas介导的半胱氨酸蛋白酶CPP32的激活、其死亡底物PARP的裂解以及Ramos-伯基特淋巴瘤B细胞中的细胞凋亡。
Cell Immunol. 1997 Nov 1;181(2):139-52. doi: 10.1006/cimm.1997.1211.
3
Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.Bcl-xL表达上调可保护CD40激活的人B细胞免受Fas介导的凋亡。
Cell Immunol. 1996 Oct 10;173(1):149-54. doi: 10.1006/cimm.1996.0260.
4
Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36.通过CD40和白细胞介素-4受体信号传导在拉莫斯人B细胞中从凋亡中拯救出来的不同机制:抑制早期反应基因Berg36的作用
Eur J Immunol. 1996 Oct;26(10):2356-63. doi: 10.1002/eji.1830261013.
5
Bcl-x protects primary B cells against Fas-mediated apoptosis.Bcl-x保护原代B细胞免受Fas介导的细胞凋亡。
J Immunol. 1997 Nov 15;159(10):4834-9.
6
The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.bcl-XL在CD40介导的对WEHI-231 B淋巴瘤细胞抗μ诱导凋亡的挽救中的作用。
Eur J Immunol. 1995 May;25(5):1352-7. doi: 10.1002/eji.1830250533.
7
Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells.拉莫斯-伯基特淋巴瘤B细胞中抗原受体触发的凋亡过程中半胱天冬酶激活和底物切割的时间顺序。
Int J Oncol. 2003 Aug;23(2):257-68.
8
Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.转化生长因子-β介导的Ramos B淋巴瘤细胞系凋亡伴随着半胱天冬酶激活和Bcl-XL下调。
Exp Cell Res. 1998 Jul 10;242(1):244-54. doi: 10.1006/excr.1998.4096.
9
Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.正常T细胞中的凋亡信号通路:Bcl-2和白细胞介素-1β转化酶家族蛋白酶抑制剂对糖皮质激素和Fas介导的细胞毒性的不同作用
J Immunol. 1996 Nov 1;157(9):3845-9.
10
Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.T细胞克隆无能的诱导导致抗性,而CD28介导的共刺激引发对Fas和Bax介导的程序性细胞死亡的易感性。
J Immunol. 1997 Oct 1;159(7):3156-67.

引用本文的文献

1
The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.Fas/CD95 受体调节自身反应性 B 细胞的死亡和抗原特异性 B 细胞的选择。
Front Immunol. 2012 Jul 25;3:207. doi: 10.3389/fimmu.2012.00207. eCollection 2012.
2
Directed evolution of mammalian anti-apoptosis proteins by somatic hypermutation.通过体细胞高频突变定向进化哺乳动物抗凋亡蛋白。
Protein Eng Des Sel. 2012 Jan;25(1):27-38. doi: 10.1093/protein/gzr052. Epub 2011 Dec 9.
3
Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis.
Bcl-XL,但不是 Bcl-2,可以保护人 B 淋巴瘤细胞系免受紫锥菊内酯诱导的细胞凋亡。
Cancer Lett. 2012 May 1;318(1):53-60. doi: 10.1016/j.canlet.2011.11.035. Epub 2011 Dec 6.
4
The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway.卡波西肉瘤相关疱疹病毒的K1蛋白激活Akt信号通路。
J Virol. 2004 Feb;78(4):1918-27. doi: 10.1128/jvi.78.4.1918-1927.2004.
5
Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins.细胞因子介导的对人树突状细胞免受前列腺癌诱导凋亡的保护作用受Bcl-2蛋白家族调控。
Br J Cancer. 2000 Aug;83(4):506-13. doi: 10.1054/bjoc.2000.1289.